Friday - March 20, 2026

Muscle Invasive Bladder Cancer Market Set for Strong Growth Through 2034, Driven by Expanding Pipeline and Innovation | DelveInsight

Muscle Invasive Bladder Cancer Market The Muscle Invasive Bladder Cancer (MIBC) treatment landscape is undergoing rapid transformation, fueled by an expanding pipeline and active participation from leading pharmaceutical and biotechnology companies such as CG Oncology, Pfizer, UroGen Pharma, Janssen Research … Continue reading

HER2-Negative Breast Cancer Clinical Pipeline Witnesses Significant Growth as 70+ Companies Accelerate Therapeutic Innovation | DelveInsight

HER2-Negative Breast Cancer Clinical Trials HER2-Negative Breast Cancer companies include Genentech, CytomX Therapeutics, H3 Biomedicine, Regor Therapeutics, Immutep Limited, Merck & Co., Klus Pharma, Olema Pharmaceuticals, BeiGene, AstraZeneca, Janssen/Merck/GSK, Ono Pharmaceutical, Laekna Therapeutics, NanoMab, InSilico Medicine, TYK Medicine, Shanghai Pharmaceutical … Continue reading

Hepatic Tumor Clinical Trial Landscape Strengthens as 75+ Companies Accelerate Innovation in Emerging Therapies | DelveInsight

Hepatic Tumor Pipeline Hepatic Tumor companies include Can Fite Biopharma, MiNA Therapeutics, Medivir AB, Janssen Research & Development, LLC, Etnova Therapeutics Corp., SillaJen Biotherapeutics, Akeso Biopharma, Shanghai Junshi Biosciences, Genmab/Janssen Biotech, Bio-Thera Solutions, Ocuphire Pharma, Surface Oncology, Genoscience, Onyx Pharmaceuticals, … Continue reading

Esophageal Cancer Market to Evolve Rapidly Over the Next Decade by 2034, DelveInsight Observes | Eli Lilly, Amgen, Zymeworks, BeiGene

Esophageal Cancer Market Insights, Epidemiology and Market Forecast 2034 The Key Esophageal Cancer Companies in the market include – Eli Lilly and Company, Amgen, Zymeworks, Jazz Pharmaceuticals, Bayer, BeiGene, Innovent Biologics, Apexigen, and others. The Esophageal Cancer market is expected … Continue reading

Glioma Pipeline Expands as 180+ Pharma Companies Advance Several Novel Therapies, Finds DelveInsight | Aivita Biomedical, Denovo BioPharma, Medicenna Therapeutics, Eli Lilly, Candel Therapeutics

Glioma – Pipeline Insight, 2026 DelveInsight’s “Glioma – Pipeline Insight, 2026” report provides comprehensive insights about 180+ companies, including Aivita Biomedical, Inc., Denovo BioPharma, Medicenna Therapeutics, Inc., Eli Lilly and Company, Candel Therapeutics, Mustang Bio, AstraZeneca, Boehringer Ingelheim, Daiichi Sankyo, … Continue reading

Cutaneous Squamous Cell Carcinoma Pipeline Grows as 45+ Pharma Companies Advance Novel Skin Cancer Therapies, Finds DelveInsight | Incyte, Shanghai Henlius Biotech, Novartis, Rakuten Medical, Roche, G

Cutaneous Squamous Cell Carcinoma (CSCC) – Pipeline Insight, 2026 DelveInsight’s “Cutaneous Squamous Cell Carcinoma (CSCC) – Pipeline Insight, 2026” report provides comprehensive insights about 45+ companies, such as Incyte Corporation, Shanghai Henlius Biotech, Novartis, Rakuten Medical, Morphogenesis, Genentech, Berg Pharma, … Continue reading

Telehealth Market Poised for Exceptional Growth at 31.81% CAGR Through 2034: DelveInsight | Teladoc Health, Koninklijke Philips N.V., and Siemens Healthineers

Global Telehealth Market Insights Key global players include Teladoc Health, Inc., Siemens Healthineers AG, Cisco Systems, Inc., Koninklijke Philips N.V., IBM Corporation, Medtronic, American Well Corporation, CareCloud, Inc., GlobalMed Holding LLC., Doctor On Demand by Included Health, Inc., derma2go Deutschland … Continue reading

Fuchs Endothelial Corneal Dystrophy Clinical Trial Pipeline Accelerates as 5+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

DelveInsight’s “Fuchs Endothelial Corneal Dystrophy Pipeline Insight 2026” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in the Fuchs Endothelial Corneal Dystrophy pipeline landscape. It covers the Fuchs Endothelial Corneal Dystrophy pipeline drug profiles, including clinical and … Continue reading

Breast Cancer Clinical Trial Gains Momentum: 250+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s “Breast Cancer Pipeline Insight 2026” report provides comprehensive insights about 250+ Breast Cancer companies and 300+ pipeline drugs in the Breast Cancer pipeline landscape. It covers the Breast Cancer pipeline drugs profiles, including clinical and nonclinical stage products. It … Continue reading

Wet-Age Related Macular Degeneration Treatment Pipeline Shows Strong Momentum as 60+ Pharma Companies in the Race | DelveInsight

DelveInsight’s “Wet-AMD Pipeline Insight 2026” report provides comprehensive insights about 60+ companies and 75+ pipeline drugs in the Wet-AMD pipeline landscape. It covers the Wet-AMD Pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Wet-AMD Pipeline … Continue reading